Page last updated: 2024-10-25

cisapride and Fasting Hypoglycemia

cisapride has been researched along with Fasting Hypoglycemia in 1 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lu, J1
Shi, TT1
Yuan, SS1
Xie, RR1
Zhao, RX1
Zhu, JJ1
Yang, JK1

Other Studies

1 other study available for cisapride and Fasting Hypoglycemia

ArticleYear
Cisapride induced hypoglycemia
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Animals; Blood Glucose; Cisapride; Ether-A-Go-Go Potassium Channels; Glucose; HEK293 Cells; Humans;

2022